Vimarsana
Biggest News Aggregation in the World

Risk Subgroups News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Risk Subgroups. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Risk Subgroups Today - Breaking & Trending Today

New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone- - Vimarsana News

New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone-

Published: February 16, 2023

New post hoc subgroup analyses from Phase III ARASENS trial in mHSPC show that NUBEQA plus androgen deprivation therapy (ADT) and docetaxel compared to ADT and docetaxel increased overall survival (OS) in specific subgroups with various types of metastatic disease burden and risk1Incidence of adverse events was simi...

Source: pharmiweb.com
Related Topics:
United StatesNew ZealandBayer CrossBayer Healthcare PharmaceuticalsOrion CorporationAmerican Cancer SocietyProstate Cancer Trials GroupAmerican SocietyClinical Oncology GenitourinaryCancers SymposiumNew Zealand UrogenitalHeart DiseaseFetal ToxicityCombinedp GpPrescribing InformationPlus Androgen Deprivation TherapyMetastatic Hormone Sensitive Prostate CancerDisease VolumeRisk SubgroupsHormone Sensitive ProstateMetastatic Castration Sensitive Prostate CancerCancer StatisticsMortality WorldwideCancer JournalProstate Cancer
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines | JAMA - Vimarsana News

Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines | JAMA

Published: September 26, 2022

This retrospective cohort study assesses incidence of breakthrough COVID-19 and hospitalization with COVID-19 pneumonia or death among adults who received a vac

Source: jamanetwork.com
Related Topics:
San FranciscoUnited StatesJ Daniel KellyS Janssen JohnsonAmyj MarkowitzUniversity Of CaliforniaNational Institute Of AllergyVa Research Career ScientistNational Institutes Of HealthDrug AdministrationUs Centers For DiseaseUs Veterans Health AdministrationVa Clinical Science ResearchVeterans Health AdministrationOr FoundationNational Surveillance ToolHealth ProblemsInternational Statistical Classification Of DiseasesDisease ControlHealth AdministrationData SourcesVeterans AffairsCorporate DataSurveillance ToolInternational Statistical Classification